Urinary tract infections in kidney transplant patients admitted to hospital: A real-life experience.

世界移植杂志 Pub Date : 2025-06-18 DOI:10.5500/wjt.v15.i2.99554

Biagio Pinchera, Rosa Carrano, Elisa Schettino, Alessia D'Agostino, Emilia Trucillo, Federica Cuccurullo, Fabrizio Salemi, Amerigo Piccione, Ivan Gentile

{"title":"Urinary tract infections in kidney transplant patients admitted to hospital: A real-life experience.","authors":"Biagio Pinchera, Rosa Carrano, Elisa Schettino, Alessia D'Agostino, Emilia Trucillo, Federica Cuccurullo, Fabrizio Salemi, Amerigo Piccione, Ivan Gentile","doi":"10.5500/wjt.v15.i2.99554","DOIUrl":null,"url":null,"abstract":"Background: Urinary tract infections (UTIs) in kidney transplant patients are a challenge.Aim: To evaluate epidemiology, clinical status, therapeutic management, and clinical outcome of kidney transplant patients in a university hospital for UTI.Methods: We conducted a retrospective observational study, enrolling all kidney transplant patients hospitalized for UTI, with the objective to evaluate the epidemiology, clinical status, therapeutic management, and clinical outcome of kidney transplant patients.Results: From our real-life experience, infection with multidrug-resistant germs was confirmed as a risk factor for the severe evolution of the infection. At the same time, the re-evaluation of immunosuppressive therapy could be an important therapeutic strategy in the course of infection.Conclusion: Prompt initiation of empiric antibiotic therapy upon initiation of microbiological investigations may reduce the risk of severe infection progression.","PeriodicalId":65557,"journal":{"name":"世界移植杂志","volume":"15 2","pages":"99554"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11886297/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"世界移植杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5500/wjt.v15.i2.99554","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Urinary tract infections (UTIs) in kidney transplant patients are a challenge.

Aim: To evaluate epidemiology, clinical status, therapeutic management, and clinical outcome of kidney transplant patients in a university hospital for UTI.

Methods: We conducted a retrospective observational study, enrolling all kidney transplant patients hospitalized for UTI, with the objective to evaluate the epidemiology, clinical status, therapeutic management, and clinical outcome of kidney transplant patients.

Results: From our real-life experience, infection with multidrug-resistant germs was confirmed as a risk factor for the severe evolution of the infection. At the same time, the re-evaluation of immunosuppressive therapy could be an important therapeutic strategy in the course of infection.

Conclusion: Prompt initiation of empiric antibiotic therapy upon initiation of microbiological investigations may reduce the risk of severe infection progression.

查看原文本刊更多论文

住院肾移植患者的尿路感染：真实的经历。

背景：肾移植患者的尿路感染（uti）是一个挑战。目的：评价某大学附属医院肾移植患者尿路感染的流行病学、临床状况、治疗管理及临床结果。方法：我们对所有因尿路感染住院的肾移植患者进行回顾性观察研究，目的是评估肾移植患者的流行病学、临床状况、治疗管理和临床转归。结果：根据我们的实际经验，多重耐药细菌感染被确认为感染严重演变的危险因素。同时，重新评估免疫抑制治疗可作为感染过程中重要的治疗策略。结论：在开始微生物学调查后立即开始经验性抗生素治疗可降低严重感染进展的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

世界移植杂志

CiteScore

3.50

自引率

0.00%

发文量

293